Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3742057018 | Product containing only pembrolizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3742058011 | Pembrolizumab only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1166861000172113 | produit contenant seulement du pembrolizumab sous forme parentérale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1230241000172116 | product dat enkel pembrolizumab in parenterale vorm bevat | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only pembrolizumab in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing only pembrolizumab in parenteral dose form (medicinal product form) | Is a | Product containing pembrolizumab in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing only pembrolizumab in parenteral dose form (medicinal product form) | Is a | Product containing only pembrolizumab (medicinal product) | true | Inferred relationship | Some | ||
| Product containing only pembrolizumab in parenteral dose form (medicinal product form) | Has active ingredient | Pembrolizumab (substance) | true | Inferred relationship | Some | 1 | |
| Product containing only pembrolizumab in parenteral dose form (medicinal product form) | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Product containing only pembrolizumab in parenteral dose form (medicinal product form) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | True | Product containing only pembrolizumab in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing precisely pembrolizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) | Is a | True | Product containing only pembrolizumab in parenteral dose form (medicinal product form) | Inferred relationship | Some |
Reference Sets
FHIR